BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16167086)

  • 1. MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO).
    Kennedy AM; Inada M; Krane SM; Christie PT; Harding B; López-Otín C; Sánchez LM; Pannett AA; Dearlove A; Hartley C; Byrne MH; Reed AA; Nesbit MA; Whyte MP; Thakker RV
    J Clin Invest; 2005 Oct; 115(10):2832-42. PubMed ID: 16167086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linkage studies of a Missouri kindred with autosomal dominant spondyloepimetaphyseal dysplasia (SEMD) indicate genetic heterogeneity.
    Gertner JM; Whyte MP; Dixon PH; Pang JT; Trump D; Pearce SH; Wooding C; Thakker RV
    J Bone Miner Res; 1997 Aug; 12(8):1204-9. PubMed ID: 9258750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice.
    Stickens D; Behonick DJ; Ortega N; Heyer B; Hartenstein B; Yu Y; Fosang AJ; Schorpp-Kistner M; Angel P; Werb Z
    Development; 2004 Dec; 131(23):5883-95. PubMed ID: 15539485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia.
    Lausch E; Keppler R; Hilbert K; Cormier-Daire V; Nikkel S; Nishimura G; Unger S; Spranger J; Superti-Furga A; Zabel B
    Am J Hum Genet; 2009 Aug; 85(2):168-78. PubMed ID: 19615667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycine to aspartic acid substitution of COL2A1 in a family with the Strudwick variant of spondyloepimetaphyseal dysplasia.
    Tysoe C; Saunders J; White L; Hills N; Nicol M; Evans G; Cole T; Chapman S; Pope FM
    QJM; 2003 Sep; 96(9):663-71. PubMed ID: 12925722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new form of severe spondyloepimetaphyseal dysplasia: clinical and radiological characterization.
    Isidor B; Geffroy L; de Courtivron B; Le Caignec C; Thiel CT; Mortier G; Cormier-Daire V; David A; Toutain A
    Am J Med Genet A; 2013 Oct; 161A(10):2645-51. PubMed ID: 23956136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan.
    Tompson SW; Merriman B; Funari VA; Fresquet M; Lachman RS; Rimoin DL; Nelson SF; Briggs MD; Cohn DH; Krakow D
    Am J Hum Genet; 2009 Jan; 84(1):72-9. PubMed ID: 19110214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysspondyloenchondromatosis (DSC) associated with COL2A1 mutation: Clinical and radiological overlap with spondyloepimetaphyseal dysplasia-Strudwick type (SEMD-S).
    Merrick B; Calder A; Wakeling E
    Am J Med Genet A; 2015 Dec; 167A(12):3103-7. PubMed ID: 26250472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type.
    Tiller GE; Polumbo PA; Weis MA; Bogaert R; Lachman RS; Cohn DH; Rimoin DL; Eyre DR
    Nat Genet; 1995 Sep; 11(1):87-9. PubMed ID: 7550321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second individual with rhizomelic spondyloepimetaphyseal dysplasia and homozygous variant in GNPNAT1.
    Sabbagh Q; Alkar F; Patte K; Prodhomme O; Janel C; Touraine R; Jeandel C; Geneviève D
    Eur J Med Genet; 2022 Jun; 65(6):104495. PubMed ID: 35427807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spondyloepimetaphyseal dysplasia EXTL3-deficient type: Long-term follow-up and review of the literature.
    Akalın A; Taskiran EZ; Şimşek-Kiper PÖ; Utine E; Alanay Y; Özçelik U; Boduroğlu K
    Am J Med Genet A; 2021 Oct; 185(10):3104-3110. PubMed ID: 34089299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IPSC reprogramming of two patients with spondyloepimetaphyseal dysplasia (SEMD, biglycan type).
    De Kinderen P; Peeters S; Rabaut L; Mortier G; Ponsaerts P; Loeys B; Verstraeten A; Meester JAN
    Stem Cell Res; 2023 Mar; 67():103024. PubMed ID: 36640472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Ninein (NIN) mutation in a family with spondyloepimetaphyseal dysplasia with joint laxity (leptodactylic type)-like phenotype.
    Grosch M; Grüner B; Spranger S; Stütz AM; Rausch T; Korbel JO; Seelow D; Nürnberg P; Sticht H; Lausch E; Zabel B; Winterpacht A; Tagariello A
    Matrix Biol; 2013; 32(7-8):387-92. PubMed ID: 23665482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A de novo variant in MMP13 identified in a patient with dominant metaphyseal anadysplasia.
    Song C; Li N; Hu X; Shi Y; Chen L; Zhou T; Xu X; Shen J; Zhu M
    Eur J Med Genet; 2019 Nov; 62(11):103575. PubMed ID: 30439533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COL2A1-related skeletal dysplasias with predominant metaphyseal involvement.
    Walter K; Tansek M; Tobias ES; Ikegawa S; Coucke P; Hyland J; Mortier G; Iwaya T; Nishimura G; Superti-Furga A; Unger S
    Am J Med Genet A; 2007 Jan; 143A(2):161-7. PubMed ID: 17163530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP13 mutations are the cause of recessive metaphyseal dysplasia, Spahr type.
    Bonafé L; Liang J; Gorna MW; Zhang Q; Ha-Vinh R; Campos-Xavier AB; Unger S; Beckmann JS; Le Béchec A; Stevenson B; Giedion A; Liu X; Superti-Furga G; Wang W; Spahr A; Superti-Furga A
    Am J Med Genet A; 2014 May; 164A(5):1175-9. PubMed ID: 24648384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia.
    Egunsola AT; Bae Y; Jiang MM; Liu DS; Chen-Evenson Y; Bertin T; Chen S; Lu JT; Nevarez L; Magal N; Raas-Rothschild A; Swindell EC; Cohn DH; Gibbs RA; Campeau PM; Shohat M; Lee BH
    J Clin Invest; 2017 Apr; 127(4):1475-1484. PubMed ID: 28263186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic expressions of a Gly 154Arg mutation in type II collagen in two unrelated patients with spondyloepimetaphyseal dysplasia (SEMD).
    Kaitila I; Körkkö J; Marttinen E; Ala-Kokko L
    Am J Med Genet; 1996 May; 63(1):111-22. PubMed ID: 8723096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel RPL13 Variants and Variable Clinical Expressivity in a Human Ribosomopathy With Spondyloepimetaphyseal Dysplasia.
    Costantini A; Alm JJ; Tonelli F; Valta H; Huber C; Tran AN; Daponte V; Kirova N; Kwon YU; Bae JY; Chung WY; Tan S; Sznajer Y; Nishimura G; Näreoja T; Warren AJ; Cormier-Daire V; Kim OH; Forlino A; Cho TJ; Mäkitie O
    J Bone Miner Res; 2021 Feb; 36(2):283-297. PubMed ID: 32916022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homozygous variant c.797G>A/p.(Cys266Tyr) in PISD is associated with a Spondyloepimetaphyseal dysplasia with large epiphyses and disturbed mitochondrial function.
    Girisha KM; von Elsner L; Neethukrishna K; Muranjan M; Shukla A; Bhavani GS; Nishimura G; Kutsche K; Mortier G
    Hum Mutat; 2019 Mar; 40(3):299-309. PubMed ID: 30488656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.